IP Library Granted Patent US 12,280,181
Granted Patent B2
US 12,280,181 · App. 18/176,435 · Granted Apr 22, 2025

Intravascular devices

Inventors: Hancun Chen (San Ramon, CA); Andrew S. Lee (San Jose, CA); Brent Gerberding (San Jose, CA)
Assignees: Stryker Corporation; Stryker European Operations Limited
A61L31/022A61L31/14A61B17/1214A61F2002/016A61F2002/068A61F2/90A61F2/95C22C5/04C22C27/04
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,280,181
App. No.
18/176,435
Filed
Feb 28, 2023
Granted
Apr 22, 2025
Kind
B2
Art Unit
1715
USPC
128/899
Abstract

An implantable medical device includes an elongate member having a cross-sectional dimension that is less than 0.00085 inch, wherein the elongate member is made from a material comprising a platinum-tungsten alloy having a percentage of tungsten that is at least 10% by weight or alternatively the implantable medical device includes an elongate member made from a material comprising an alloy containing rhenium.

Claims (30)

1. An implantable medical device, comprising:

an elongate member made from a material comprising an alloy containing rhenium in combination with zirconium and/or hafnium;

wherein the elongate member forms a part of a braid having a cross-section with a width W and a thickness T when the braid is unconfined outside a tube, wherein a ratio of W/T is equal to or greater than 2, wherein the braid is configured to roll up so that the cross-section of the braid has a collapsed width W′ when the braid is inside the tube, and wherein the collapsed width W′ of the cross-section when the braid is inside the tube is less than the width W of the cross-section when the braid is outside the tube.

2. The implantable medical device of claim 1 , wherein the elongate member has a cross-sectional dimension that is less than 0.00085 inch.

3. The implantable medical device of claim 1 , wherein the alloy comprises a molybdenum-rhenium alloy.

4. The implantable medical device of claim 1 , wherein the alloy comprises a tungsten-rhenium alloy.

5. The implantable medical device of claim 1 ,

wherein the implantable medical device has a longitudinal axis and a length measured in a direction of the longitudinal axis that is at least 1.2 inch,

wherein the implantable medical device is insertable lengthwise into an inner lumen of the tube having an inner lumen diameter not greater than 0.02 inch, and

wherein the implantable medical device has a column strength sufficient to allow the implantable medical device to be pushed through the lumen without undergoing buckling, kinking, or plastic deformation.

6. The implantable medical device of claim 1 , wherein the elongate member has a greater ultimate tensile strength, a greater Young's modulus, and a lesser magnetic susceptibility, respectively, than those of an identically dimensioned alternative elongate member composed of an alternative alloy that does not include Rhenium and has a percentage of tungsten that is no more than 8% by weight.

7. The implantable medical device of claim 1 , wherein the elongate member has a Young's modulus of 30 Msi or higher.

8. The implantable medical device of claim 1 , wherein the elongate member has an ultimate tensile strength (UTS) that is 350 ksi or higher.

9. The implantable medical device of claim 1 , wherein the material further comprises one or more of Ta, Ir, Rh, Ru, Mo, and Au.

10. The implantable medical device of claim 1 , wherein the alloy contains rhenium in combination with both zirconium and hafnium.

11. The implantable medical device of claim 1 , wherein the alloy contains rhenium in combination with zirconium or hafnium, but not both zirconium and hafnium.

12. An implantable medical device, comprising:

an elongate member having a cross-sectional dimension that is less than 0.00085 inch,

wherein the implantable medical device has a longitudinal axis and a length measured in a direction of the longitudinal axis that is at least 1.2 inch,

wherein the implantable medical device is insertable lengthwise into a tube having a lumen, at least a part of the lumen having a diameter not greater than 0.02 inch;

wherein the elongate member is made out of an alloy comprising rhenium in combination with zirconium and/or hafnium; and

wherein the elongate member forms a part of a braid having a cross-section with a width W and a thickness T when the braid is outside the tube, wherein a ratio of W/T is equal to or greater than 2, wherein the braid is configured to roll up so that the cross-section of the braid has a collapsed width W′ when the braid is inside the tube, and wherein the collapsed width W′ of the cross-section when the braid is inside the tube is less than the width W of the cross-section when the braid is outside the tube.

13. The implantable medical device of claim 12 , wherein the implantable medical device has a column strength sufficient to allow the implantable medical device to be pushed through the lumen of the tube without undergoing buckling, kinking, or plastic deformation.

14. The implantable medical device of claim 12 , wherein the alloy comprises a molybdenum-rhenium alloy.

15. The implantable medical device of claim 12 , wherein the alloy comprises a tungsten-rhenium alloy.

16. The implantable medical device of claim 12 , wherein the elongate member has a Young's modulus of 30 Msi or higher.

17. The implantable medical device of claim 12 , wherein the elongate member has an ultimate tensile strength (UTS) that is 350 ksi or higher.

18. The implantable medical device of claim 12 , wherein the material further comprises one or more of Ta, Ir, Rh, Ru, Mo, and Au.

19. The implantable medical device of claim 1 , wherein the braid is configured to roll up longitudinally around a longitudinal axis of the tube when the braid is inside the tube.

20. The implantable medical device of claim 12 , wherein the braid is configured to roll up longitudinally around a longitudinal axis of the tube when the braid is inside the tube.

Assignments (2)
CHANGE OF ADDRESS Recorded Dec 18, 2024
From: STRYKER CORPORATION
To: STRYKER CORPORATION
Reel/Frame 069737/0184 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 1, 2023
From: CHEN, HANCUN; LEE, ANDREW S.; GERBERDING, BRENT
To: STRYKER CORPORATION; STRYKER EUROPEAN OPERATIONS LIMITED
Reel/Frame 062847/0398 →
Continuity (3)
Continuation 16872124 · May 11, 2020
Continuation In Part 16567845 · Sep 11, 2019
Related Publication 20230201428A1 · Jun 29, 2023
References Cited (47)
US 6051021A · Frid · 2000 [cited by applicant]
US 6322576B1 · Wallace et al. · 2001 [cited by applicant]
US 6458119B1 · Berenstein · 2002 [cited by examiner]
US 7250058B1 · Pacetti et al. · 2007 [cited by applicant]
US 7842054B2 · Greene, Jr. et al. · 2010 [cited by applicant]
US 9060777B1 · Wallace · 2015 [cited by examiner]
US 9198670B2 · Hewitt et al. · 2015 [cited by applicant]
US 9597155B2 · Schewe et al. · 2017 [cited by applicant]
US 11484629B2 · Chen et al. · 2022 [cited by applicant]
US 20030077200A1 · Craig et al. · 2003 [cited by applicant]
US 20040193205A1 · Burgermeister · 2004 [cited by applicant]
US 20040220608A1 · D'Aquanni · 2004 [cited by examiner]
US 20050065545A1 · Wallace · 2005 [cited by examiner]
US 20050070990A1 · Stinson · 2005 [cited by applicant]
US 20060116711A1 · Elliott et al. · 2006 [cited by applicant]
US 20060153729A1 · Stinson · 2006 [cited by examiner]
US 20060198750A1 · Furst · 2006 [cited by examiner]
US 20070067009A1 · Gandhi et al. · 2007 [cited by applicant]
US 20070162108A1 · Carlson et al. · 2007 [cited by applicant]
US 20070280850A1 · Carlson · 2007 [cited by examiner]
US 20080185075A1 · Ishida et al. · 2008 [cited by applicant]
US 20080195194A1 · Pacetti et al. · 2008 [cited by applicant]
US 20090192585A1 · Bloom et al. · 2009 [cited by applicant]
US 20150283363A1 · Hewitt et al. · 2015 [cited by applicant]
US 20160066918A1 · Chen · 2016 [cited by examiner]
US 20180263629A1 · Murphy · 2018 [cited by examiner]
US 20180325706A1 · Hebert · 2018 [cited by examiner]
US 20190374228A1 · Wallace · 2019 [cited by examiner]
US 20200149137A1 · Roth · 2020 [cited by applicant]
US 20210069386A1 · Chen et al. · 2021 [cited by applicant]
CN 109385591A · 2019 [cited by applicant]
WO WO2004022122 · 2004 [cited by applicant]
WO WO2019014206 · 2019 [cited by applicant]
WO WO2019014206A1 · 2019 [cited by applicant]
PCT Invitation to Pay Additional Fees for International Appln. No. PCT/US2020/050175, Applicant Magic Leap, Inc., dated Dec. 10, 2020 (11 pages). [cited by applicant]
PCT International Search Report and Written Opinion for International Appln. No. PCT/US2020/050175, Applicant Stryker Corporation, dated Mar. 19, 2021 (17 pages). [cited by applicant]
Non-Final Office Action for U.S. Appl. No. 16/567,845 dated Mar. 31, 2022. [cited by applicant]
Foreign OA for CN Patent Appln. No. 202080062884.7 dated Jun. 1, 2023 (with English translation provided by foreign agent). [cited by applicant]
Foreign OA for CN Patent Appln. No. 202080062884.7 dated Dec. 5, 2023 (with English translation provided by foreign agent). [cited by applicant]
Non-Final Office Action for U.S. Appl. No. 18/315,502 dated Dec. 21, 2023. [cited by applicant]
Foreign Comm Response for EP Patent Appln. No. 23153653.3 dated Jan. 30, 2024. [cited by applicant]
Foreign OA for CN Patent Appln. No. 202080062884.7 dated Mar. 12, 2024 (with English translation of Examiner's Comments). [cited by applicant]
Foreign Rejection Decision for CN Patent Appln. No. 202080062884.7 dated May 17, 2024 (With translated English comments from examiner). [cited by applicant]
Final Office Action for U.S. Appl. No. 18/315,502 dated Apr. 11, 2024. [cited by applicant]
Foreign Exam Report for IN Patent Appln. No. 202247011359 dated Sep. 4, 2024. [cited by applicant]
Non-Final Office Action for U.S. Appl. No. 18/498,803 dated Aug. 14, 2024. [cited by applicant]
Lou et al. CN109385591 translation 2018 (year 2018). [cited by applicant]